Skip to search formSkip to main contentSkip to account menu

PRS-110

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

89Zr-PRS-110

Broader (1)

Lipocalins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
- PRS-110 PET Tracer 89 the MET-Specific Anticalin In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with
Published online: March 10, 2014. 2014;55:665-671. J Nucl Med. Vries, Laurent Audoly and Shane A. Olwill Allersdorfer, Martin H… 
2013
2013
Abstract 2664: Next generation PET imaging agents: The development of radiolabeled c-Met specific Anticalin89Zr-PRS-110 with diagnostic and therapeutic drug monitoring applications.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC The oncogene c-Met is a clinically validated target… 
2013
2013
Large Molecule Therapeutics A Highly Potent and Speci fi c MET Therapeutic Protein Antagonist with Both Ligand-Dependent and Ligand-Independent Activity
Activation of theMEToncogenic pathwayhas been implicated in thedevelopment of aggressive cancers that are difficult to treat with… 
2012
2012
Abstract 3875: Exploiting the Anticalin therapeutic protein platform for the treatment of cMet ligand-independent and dependent tumors - discovery and characterization of a highly specific and potent…
Background: Activation of the c-Met oncogenic pathway has been implicated in the development of aggressive cancers which are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)